Clinical Trial Update: Optimization of Treatment With Adalimumab (Humira)

View source ↗

Summary

A completed clinical trial update on optimizing treatment with adalimumab (Humira) for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Rheumatoid Arthritis (RA) | Status: COMPLETED